Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
Jeffrey Rohrer, Ph.D.
Jeff earned his Ph. D in chemistry with a concentration in biochemistry from the University of Delaware. After completing a postdoctoral fellowship in the Biochemistry Department at North Carolina State University, Jeff joined Thermo Fisher Scientific (formerly Dionex Corporation) where he has worked the past 24 years. Dr. Rohrer is the Director of Applications Development, Dionex Products, including HPAE-PAD for carbohydrate analysis.